Medicines for Malaria Venture (MMV): Malaria Drug Discovery Projects - LOI

MMV welcomes proposals in the following areas:

1. Compounds having activity against Plasmodium falciparum blood stages and ideally an inability to select resistant mutants in vitro(TCP1)
2. Compounds having activity against Plasmodium falciparum liver stages for use in prophylaxis (TCP4)
3. Compounds addressing the key priorities of the malaria eradication agenda (TCP3 and TCP5)

Funding information unspecified. No overhead.

https://www.mmv.org/research-development/information-scientists/call-proposals/19th-call-proposals